Report #2881566

Received Jan 12, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Jan 6, 2026
Onset: Jan 6, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	7GF79	—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

Administered expired booster of Menveo; This non-serious case was reported by a other health professional and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 7GF79, expiry date 31-DEC-2025) for prophylaxis. On 06-JAN-2026, the patient received Menveo .5 ml. On 06-JAN-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Administered expired booster of Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 08-JAN-2026 The patient was asymptomatic. The reporter was consented to follow up.